首页|喜炎平联合沙丁胺醇对儿童哮喘及辅助性T细胞2/辅助性T细胞17表达的作用

喜炎平联合沙丁胺醇对儿童哮喘及辅助性T细胞2/辅助性T细胞17表达的作用

扫码查看
目的 分析喜炎平联合沙丁胺醇治疗儿童哮喘的临床疗效及对患儿外周血辅助性T细胞(T helper cell,Th)2/Th17表达的影响.方法 选择到本院就诊的哮喘患儿76例,用随机数字表法分为对照组(n=38,予以常规治疗联合沙丁胺醇治疗)和研究组(n=38,在对照组治疗的基础上加用喜炎平).比较2组临床疗效、肺功能和复发率,并检测外周血Th2、Th17表达情况与循环内皮细胞(circulating endothelial cells,CEC)、白三烯C4(leukotriene C4,LTC4)水平.结果 研究组的总有效率[92.11%(35/38)]高于对照组[71.05%(27/38)](χ²=5.604,P=0.018).治疗后,2组外周血Th2、Th17细胞水平低于治疗前(P<0.05),血清白细胞介素(interleukin,IL)-4、IL-17水平较治疗前降低(P<0.05),CEC、LTC4水平低于治疗前(P<0.05),且研究组以上指标均低于对照组(P<0.05).治疗后,2组肺功能指标检测结果[第1秒用力呼气容积(forced expiratory volume in 1 second,FEV1)、FEV1/用力肺活量(forced vital capacity,FVC)、呼气峰值流速(peak expiratory flow,PEF)和呼气高峰流量(peak expiratory flow rate,PEFR)]高于治疗前(P<0.05),且研究组肺功能指标检测结果高于对照组(P<0.05).随访24周,研究组复发率[7.89%(3/38)]低于对照组[26.32%(10/38)](χ²=4.547,P=0.033).结论 喜炎平联合沙丁胺醇可改善哮喘患儿肺功能与免疫机制失衡,降低CEC、LTC4水平,临床疗效显著,且复发率低.
Effects of Xiyanping combined with salbutamol on asthma and T helper cell 2/T helper cell 17 expression in children
Objective To analyze the clinical efficacy of Xiyanping combined with salbutamol in the treatment of children with asthma and its impacts on the expression of T helper cell(Th)2/Th17 in children's peripheral blood.Methods Seventy-six children with asthma who came to our hospital for treatment were gathered and grouped into control group(n=38,conventional treatment com-bined with albuterol)and research group(n=38,added Xiyanping on the basis of the control group).The clinical efficacy,lung func-tion and recurrence rate were compared,and the expression of Th2 and Th17 in peripheral blood and circulating endothelial cell(CEC)and leukotriene C4(LTC4)were detected.Results The total effective rate of the research group was 92.11%(35/38),which was higher than that of the control group[71.05%(27/38)](χ2=5.604,P=0.018).The levels of peripheral blood Th2,Th17 cells,serum interleukin(IL)-4,IL-17,the levels of CEC and LTC4 were lower than those before treatment(P<0.05),and the above indexes in the research group were lower than those in the control group(P<0.05).The test results of pulmonary function indicators[forced expiratory volume in first second(FEV1),FEV1/forced vital capacity(FVC),peak expiratory flow(PEF),and peak expiratory flow rate(PEFR)]in the 2 groups were increased after treatment(P<0.05),and the test results of lung function in-dexes in the research group were higher than those in the control group(P<0.05).After 24 weeks of follow-up,the recurrence rate of the research group was 7.89%(3/38),which was lower than that of the control group[26.32%(10/38)](χ2=4.547,P=0.033).Conclusion Xiyanping combined with salbutamol can improve the pulmonary function and immune system imbalance in children with asthma,and reduce the levels of CEC and LTC4.The clinical healing efficacy is obvious,and the recurrence rate is low.

Xiyanpingsalbutamolchildrenasthmaclinical efficacy

吴岳彪、蔡露良、林鲁飞

展开 >

海口市第四人民医院儿科,海口 571100

喜炎平 沙丁胺醇 儿童 哮喘 临床疗效

海南省卫生计生行业科研项目

160103203-4A2003

2024

西北药学杂志
西安交通大学,陕西省药学会

西北药学杂志

CSTPCD
影响因子:0.912
ISSN:1004-2407
年,卷(期):2024.39(1)
  • 19